Abstract
The general reliance on blinded placebo-controlled randomized trials, both to approve drugs and to set their recommended dosages, although statistically sound for some purposes, may be statistically naïve in the context of guiding general medical practice. Briefly, the reason is that medical prescriptions are unblinded, and so patients who receive drugs in practice receive both the active medical effect of the drug, as estimated in blinded trials, as well as any “placebo effects”, rarely carefully defined or estimated, but intuitively defined as the extra effect, on “you”, when you think you are being actively treated, even when in fact you may not be receiving anything that actually works.
Similar content being viewed by others
References
Angrist JD, Imbens GW, Rubin DB (1996) Identification of causal effects using instrumental variables. Applications invited discussion article, with discussion and rejoinder. J Am Stat Assoc 91(434):444–472
Efron B, Feldman D (1991) Compliance as an explanatory variable in clinical trials. J Am Stat Assoc 86:9–17
Frangakis CE, Rubin DB (2002) Principal stratification in causal inference. Biometrics 58(1):21–29
Frangakis CE, Rubin DB, Zhou XH (2002) Clustered encouragement designs with individual noncompliance: bayesian inference with randomization, and application to advance directive forms with discussion and rejoinder. Biostatistics 3(2):147–177
Hirano K, Imbens G, Rubin DB, Zhou XH (2000) Assessing the effect of an influenza vaccine in an encouragement design. Biostatistics 1:69–88
Holland PW (1986) Statistics and causal inference. J Am Stat Assoc 81(396):945–960
Imbens G, Rubin DB (2015) Causal inference for statistics, social, and biomedical sciences: an introduction. Cambridge University Press, New York
Jaynes J (1976) The origin of consciousness in the break-down of the bicameral mind. Houghton Mifflin Company, Boston
Jin H, Rubin DB (2008) Principal stratification for causal inference with extended partial compliance: application to Efron–Feldman data. J Am Stat Assoc 103:101–111
Li F, Mealli F (2014) A conversation with Donald B. Rubin. Stat Sci 29(3):439–457
Rubin DB (1974) Estimating causal effects of treatments in randomized and nonrandomized studies. J Educ Psychol 66(5):688–701
Rubin DB (1975) Bayesian inference for causality: the importance of randomization. In: The Proceedings of the Social Statistics Section of the American Statistical Association. pp 233–239
Rubin DB (1976) Inference and missing data. Biometrika 63(3):581–592
Rubin DB (1977) Assignment to treatment group on the basis of a covariate. J Educ Stat 2(1):1–26
Rubin DB (1978) Bayesian inference for causal effects: the role of randomization. Ann Stat 6(1):34–58
Rubin DB (1979) Using multivariate matched sampling and regression adjustment to control bias in observational studies. J Am Stat Assoc 74(366):318–328
Rubin DB (1980) Comment on “Randomization analysis of experimental data in the Fisher randomization test” by Basu. J Am Stat Assoc 75(371):591–593
Rubin DB (2006) Matched sampling for causal effects. Cambridge University Press, New York
Rubin DB (2010) Reflections stimulated by the comments of Shadish (2010) and West and Thoemmes (2010). Psychol Methods 15(1):38–46
Rubin DB (2019) Essential concepts of causal inference: a remarkable history and an intriguing future. Biostat Epidemiol (to appear)
Tomkins SS (1962) Affect imagery consciousness. Tavistock, London
Tversky A, Kahneman D (1974) Judgment under uncertainty: heruristics and biases. Science 185(4157):1124–1131
Acknowledgements
I wish to thank the editorial board for their helpful comments and their encouragement to expand Section 1 to include more details of my transitions between academic fields.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Maomi Ueno.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Rubin, D.B. The practical importance of understanding placebo effects and their role when approving drugs and recommending doses for medical practice. Behaviormetrika 47, 5–18 (2020). https://doi.org/10.1007/s41237-019-00091-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s41237-019-00091-7